CITI/CALL/ZOETIS/200/0.1/16.01.25 | Delayed Deutsche Boerse AG 01:33:29 2024-06-12 pm EDT | ||
| 0.85 EUR | -11.46% |
|
| Current month | +41.18% | ||
| 1 month | +15.66% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 0.85 | -11.46% |
| 24-06-11 | 0.96 | -6.80% |
| 24-06-10 | 1.03 | +10.75% |
| 24-06-07 | 0.93 | +4.49% |
| 24-06-06 | 0.89 | -6.32% |
Delayed Quote Deutsche Boerse AG
Last update June 12, 2024 at 01:33 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | 
Citi
|
| WKN | KH8A6V |
| ISIN | DE000KH8A6V3 |
| Date issued | 2023-07-24 |
| Strike | 200 $ |
| Maturity | 2025-01-16 (218 Days) |
| Parity | 10 : 1 |
| Emission price | 1.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.7 € |
|---|---|
| Lowest since issue | 0.26 € |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
178.5
USD
Average target price
211.2
USD
Spread / Average Target
+18.29%
- Stock Market
- Warrants
- Warrant
